Tell the FDA that St. John's Wort Shouldn't Be Hidden Behind the Counter!

Pharmacists Planning Service is petitioning the FDA to change the designation of St. John’s Wort from “herbal dietary supplement status” to “behind pharmacy counter status” (BPCS)—a designation that requires pharmacist consultation. But the herbal supplement is far safer than any other depression medication, has been used for many years in Germany and other countries to treat mild depression, and is as effective as standard antidepressants with fewer side effects.

Making its purchase contingent on a consultation with a pharmacist might dissuade the consumer from taking St. John’s Wort, and would give a false impression that SJW is dangerous.

Tell FDA that St. John’s Wort is a safe, and that the safeguards already built into the system with the warning on the label are completely adequate. No reclassification to “behind the counter status” is even remotely warranted.

Please personalize and add your own comments if you have time!


  • Stephen Ostroff


*Required fields


Dear [Decision Maker],

[Your Name]
[Your Address]
[City, State ZIP]